1. Pink Sheet
  2. >>R&D
  3. >>Clinical Trials

Expanded Access Programs Eyed For Data-Gathering Purposes

 
• By Sue Sutter

Protocol-driven approach could generate reliable data about investigational drug's efficacy and safety in patients who do not qualify for clinical trials, PhRMA's Moscicki says; Johns Hopkins' Sharfstein cautions this could turn expanded access programs into burdensome studies that take away from primary purpose of providing access to investigational therapies.

Are you Eligible? check boxes

There appears to be growing momentum for designing expanded access programs to serve as data-gathering tools to learn more about investigational drugs' efficacy and safety.

Appropriately designed, protocol-driven expanded access programs, conducted in patient populations that are not covered by ongoing clinical trials, could generate...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Clinical Trials

Belgium Slashes Clinical Trial Review Times In Push To Draw More Studies

 
• By Neena Brizmohun

Deadlines for reviewing applications for mononational trials in Belgium will be cut by 50%.

UK Regulator Expands Team To Assess Computer-Simulated Trials

 
• By Eliza Slawther

The UK MHRA is looking to support drug sponsors in using in silico data during the drug development process – a move that will reduce the use of animal models.

Brazil’s ‘Milestone’ Clinical Research Decree Expected To Double Clinical Trials

 
• By Francesca Bruce

A new decree in Brazil establishes a new ethics governance and operational structure in clinical research and seeks to better protect clinical trial participants.

ACCESS Consortium To Harmonize Clinical Trial Process Across Five Nations

 
• By Eliza Slawther

Clinical trial sponsors could soon benefit from a streamlined clinical trial approval process in Australia, Canada, Singapore, Switzerland and the UK under a new ACCESS Consortium project.

More from R&D

ACCESS Consortium To Harmonize Clinical Trial Process Across Five Nations

 
• By Eliza Slawther

Clinical trial sponsors could soon benefit from a streamlined clinical trial approval process in Australia, Canada, Singapore, Switzerland and the UK under a new ACCESS Consortium project.

Cancer Patient-Reported Outcomes Find Fertile Ground In GVHD, Myelofibrosis Labeling

 
• By Bridget Silverman

The FDA reviewed its efforts to bring PROs into cancer drug development at its 10th annual workshop on clinical outcome assessment in cancer trials.

Clinical Trials To Thrive Under New WHO Global Network

 
• By Anabel Costa-Ferreira

The World Health Organization’s Global Clinical Trials Forum brings optimism for pharma companies and other stakeholders, as it aims to strengthen the clinical trials environment and infrastructure across nations.